Finch Therapeutics Group Inc. (FNCH)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
Q1  2024 | |||||
≡ | Seth Klarman - Baupost Group | Sell 100.00% | 67,296 | 0.01 | |
Q2  2023 | |||||
≡ | Seth Klarman - Baupost Group | Reduce 0.01% | 4 | 0.00 | |
Q1  2023 | |||||
≡ | Seth Klarman - Baupost Group | Add 98.13% | 33,333 | 0.00 | |
Q4  2022 | |||||
≡ | Seth Klarman - Baupost Group | Reduce 9.27% | 3,470 | 0.00 | |
Q1  2022 | |||||
≡ | Seth Klarman - Baupost Group | Reduce 0.81% | 305 | 0.00 | |
Q4  2021 | |||||
≡ | Seth Klarman - Baupost Group | Reduce 6.28% | 2,531 | 0.01 | |
Q1  2021 | |||||
≡ | Seth Klarman - Baupost Group | Buy | 40,271 | 0.15 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.